Figure 3
The percentage of dual staining of CEM/A7R and CCRF-CEM tested by flow cytometry using Annexin V and PI after treatment with control Mab BCP7 (anti-MUC1) (A and D) or 25 μg ml−1 of anti-Cripto Mab C4 (B and E), C13 (C and F) for 4 h.
